AIM ImmunoTech logo
AIM ImmunoTech AIM
$ 0.11 -8.33%
report update icon

Quarterly report 2026-Q3
added 11-12-2026

AIM ImmunoTech Accounts Payables | AIM

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.
Main types of accounts payable
Type of liabilityExample
To suppliers and contractorsGoods received but not yet paid for
Taxes and feesVAT, income tax, etc., not paid on time
SalariesEmployee wages not paid
To budgetsInsurance contributions to funds not paid
To foundersFounders provided borrowed funds
To banksOverdue loan payments
OtherFines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance
  1. Liquidity and solvency
    Accounts payable are part of short-term liabilities, so they affect liquidity ratios
  2. Financial stability
    The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
  3. Capital turnover
    Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
  4. Risks and reputation
    Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables AIM ImmunoTech

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
1.63 M 6.38 M 6.44 M 377 K 198 K 383 K 472 K 680 K 741 K 887 K 1.21 M 2.08 M 1.27 M 2.16 M 1.68 M 1.33 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.44 M 198 K 1.75 M

Quarterly Accounts Payables AIM ImmunoTech

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
443 K 480 K 1.22 M 1.63 M 1.25 M 7.3 M 6.94 M 6.38 M 6.26 M 5.46 M 6.57 M 6.44 M 2.79 M 2.15 M - 377 K 957 K 712 K 378 K 198 K 369 K 451 K 189 K 383 K 383 K 383 K 383 K 472 K 472 K 472 K 472 K 680 K 680 K 680 K 680 K 741 K 741 K 741 K 741 K 887 K 887 K 887 K 887 K 1.21 M 1.51 M 1.6 M 2.32 M 2.08 M 2.45 M 1.47 M 1.22 M 1.27 M 1.72 M 967 K 1.66 M 2.16 M 2.34 M 1.8 M 2.46 M 1.68 M 1.58 M 1.12 M 1.68 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.3 M 189 K 1.71 M

Accounts Payables of other stocks in the Biotechnology industry

Issuer Accounts Payables Price % 24h Market Cap Country
PDS Biotechnology Corporation PDS Biotechnology Corporation
PDSB
3.57 M $ 0.79 -2.58 % $ 36.6 M usaUSA
Geron Corporation Geron Corporation
GERN
11.3 M $ 0.87 -4.76 % $ 580 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
4.98 M $ 4.65 -8.46 % $ 339 M usaUSA
Gossamer Bio Gossamer Bio
GOSS
5.96 M $ 10.69 -4.81 % $ 2.44 B usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
3.68 M $ 54.39 -3.96 % $ 4.68 B usaUSA
MediciNova MediciNova
MNOV
625 K $ 1.3 2.36 % $ 63.8 M usaUSA
PTC Therapeutics PTC Therapeutics
PTCT
45.5 M $ 56.23 -3.59 % $ 4.47 B usaUSA
Pulmatrix Pulmatrix
PULM
651 K $ 1.24 -12.34 % $ 4.53 B usaUSA
Immunome Immunome
IMNM
3.34 M $ 15.69 -5.54 % $ 1.37 B usaUSA
Incyte Corporation Incyte Corporation
INCY
210 M $ 114.5 -1.19 % $ 22.4 B usaUSA
INmune Bio INmune Bio
INMB
550 K $ 0.82 -8.41 % $ 20.3 M usaUSA
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
939 M $ 920.38 -0.22 % $ 96.3 B usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
28.1 M $ 26.58 -2.37 % $ 4.25 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
3.81 M $ 1.06 -10.92 % $ 48.4 M israelIsrael
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
2.9 M $ 4.68 -0.53 % $ 757 M usaUSA
Kala Pharmaceuticals Kala Pharmaceuticals
KALA
986 K $ 2.73 -9.61 % $ 22.2 M usaUSA
Intellia Therapeutics Intellia Therapeutics
NTLA
20.3 M $ 10.02 5.24 % $ 1.09 B usaUSA
Adagene Adagene
ADAG
2.88 M $ 1.8 -10.56 % $ 106 M chinaChina
Denali Therapeutics Denali Therapeutics
DNLI
3.33 M $ 18.43 1.29 % $ 3.18 B usaUSA
Pfizer Pfizer
PFE
5.24 B $ 27.4 -0.62 % $ 156 B usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
45.4 M $ 10.56 -6.26 % $ 4.38 B irlandaIrlanda
ImmuCell Corporation ImmuCell Corporation
ICCC
792 K $ 11.08 -0.81 % $ 100 M usaUSA
Editas Medicine Editas Medicine
EDIT
2.6 M $ 1.63 -4.68 % $ 145 M usaUSA
Kiniksa Pharmaceuticals, Ltd. Kiniksa Pharmaceuticals, Ltd.
KNSA
2.03 M $ 93.83 0.32 % $ 6.96 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
18.4 M $ 27.54 -4.24 % $ 1.6 B usaUSA
Equillium Equillium
EQ
755 K $ 1.06 -5.36 % $ 60.7 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
579 K $ 1.32 -5.04 % $ 75.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
7.89 M $ 2.42 -1.17 % $ 128 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
10.9 M $ 17.1 -2.79 % $ 2.88 B usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
4.29 M $ 1.6 -8.86 % $ 13.8 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
13.9 M $ 112.31 -3.84 % $ 7.3 B usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
9.18 M $ 1.29 -2.28 % $ 164 M schweizSchweiz
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
17.7 M $ 32.58 -1.21 % $ 1.87 B usaUSA
Ardelyx Ardelyx
ARDX
19.2 M $ 2.99 -2.25 % $ 721 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
21.2 M $ 0.39 -8.41 % $ 100 M usaUSA
Alector Alector
ALEC
1.69 M $ 2.34 1.52 % $ 241 M usaUSA
ALX Oncology Holdings ALX Oncology Holdings
ALXO
4.91 M $ 1.06 3.43 % $ 56.9 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
166 M $ 21.12 -1.26 % $ 6.62 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
1.17 M $ 4.03 -1.11 % $ 772 M canadaCanada
Agenus Agenus
AGEN
83 M $ 5.97 -2.85 % $ 178 M usaUSA